Schedule 13D ownership disclosure
Organogenesis Holdings Inc
Class A Common Stock, par value $0.0001 per share · CUSIP: 68621F102
Event date: 2025-05-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Glenn H. NussdorfReported CIK 0001244191
Shares: 12,248,560 · Class: 9.7%
- GN 2016 Family Trust u/a/d August 12, 2016Reported CIK 0001757453
Shares: 918,680 · Class: 0.7%
- GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016Reported CIK 0001757452
Shares: 7,928,570 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-262869
- Form type
- SCHEDULE 13D/A
- Filer
- NUSSDORF GLENN H
- CIK
- CIK 1244191
- Filed
- Nov 03, 2025
- Reporting period
- May 14, 2025
- Description
- Schedule 13D beneficial ownership